To our knowledge, our study provides the first evidence showing that a vaccine targeted at CETP is able to delay the development of both atherosclerosis and NASH in HFC diet-fed rabbits. The gene discussed is CETP; the disease is metabolic dysfunction-associated steatohepatitis.